INSIGHTS ON DRUG DEVELOPMENT
-
How Can Nanoparticle Engineering Make The Difference For Alzheimer’s?
Commercial Insights Officer Jamie Unwin discusses the power of innovative nanoparticle engineering technology and AI-based digital twin.
-
Enhancing The Solubility Of High Lipophilicity Drugs Via Spray Drying
A new R&D project shows that the solubility and dissolution characteristics of Itraconazole can be improved by helping them to maintain an amorphous state after spray drying with selected hydrophilic polymers.
-
Scaling Up Your Methods With USP <621> - Part 2: Hardware
Learn about the hardware changes that allow for scaling and modernization of chromatographic methods and how mismatching particle size and liquid chromatographic systems can result in poor performance.
-
A Versatile Application For Rapid Mass Confirmation And Purity Assessment Of Biotherapeutics
We explore a streamlined integrated workflow for data acquisition, processing and reporting of deconvoluted mass data for biotherapeutics, deployable in regulated and non-regulated environments.
-
The Power Couple: CRISPR And Oligonucelotides3/4/2024
Drug design using CRISPR depends on long guide RNA (gRNA) sequences. Find out how this love match between long oligos and CRISPR works.
-
Scaling Up Your Methods with USP <621> - Part 3: Software9/22/2023
Learn how Empower Software addresses modifications to certain calculations and maintains relevant naming conventions and calculations to help customers update SOPs to prevent disruption to operations.
-
Five Inverted-Microscope Advantages For Industrial Applications1/4/2024
Learn about five of the advantages to using an inverted microscope for sample observation and industrial applications, as opposed to an upright microscope.
-
How To Overcome Bioprocess Development Challenges4/12/2022
We explain how to successfully address common process development challenges to achieve an efficient journey to market and maximize the biotherapeutic’s potential impact.
-
ACQUITY And XBridge Premier Protein SEC 250 Å Columns: A New Benchmark In Inert SEC Column Design7/5/2022
We demonstrate the performance of a new column technology designed to provide a holistic solution to the problems of undesired secondary interactions in SEC.
DRUG DEVELOPMENT SOLUTIONS
-
Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.
-
CDMOs, CMOs, and those working on pilot to scale-up operations can benefit from this single-use solution for chromatographic purification that offers easy integration and versatility in scale.
-
Optical microscope Leica DM2500 LED
Leica DM2500 LED optical microscopes are tools for demanding tasks in life science routine and research applications. With their transmitted light illumination, optical performance, and state-of-the-art accessories, they are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.
-
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.
-
Accelerating the delivery of high quality, customized media with rapid set-up times, fast turnaround, and on-time delivery.